Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
April 17, 2024 16:05 ET
|
Serina Therapeutics, Inc.
- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (NYSE...
Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
April 16, 2024 17:00 ET
|
Cingulate Inc.
KANSAS CITY, Kan., April 16, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
April 01, 2024 08:00 ET
|
Cingulate Inc.
$17.8 Million Raised Since Beginning of 2023$9.1 Million of Debt Converted to Equity at a PremiumPhase 3 ADHD Data Continues to Impress KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE) --...
Cingulate to Participate in Benzinga All Live Access Event
March 19, 2024 16:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., March 19, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Long-Acting Drug Delivery Technologies and Services Market Predicted to Reach $36.82 Billion by 2033, as Asia-Pacific Emerges with Highest CAGR
February 28, 2024 09:56 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ...
Global Advanced Drug Delivery Systems Markets and Technologies Report 2024, with Compound Annual Growth Projections Through 2028
February 19, 2024 04:29 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Markets and Technologies for Advanced Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering. The global market...
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
January 29, 2024 06:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery...
Implantable Drug Delivery Devices Market Forecasts Robust Growth with Advanced Biocompatible Material Innovations
January 24, 2024 19:56 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Implantable Drug Delivery Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The implantable drug delivery...
Drug Delivery Companies Compendium Directory 2024
January 19, 2024 09:08 ET
|
Research and Markets
Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Companies Compendium 2024" directory has been added to ResearchAndMarkets.com's offering.Accurate and timely intelligence about the drug...
Global Long-Acting Drug Delivery Technologies and Services Market 2023-2033: Navigating Regulatory Complexities, Key to Success
December 22, 2023 10:08 ET
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ...